Biogen swung to a loss as results were hurt by a double-digit decline in revenue from its core multiple sclerosis treatments.
Source link
Biogen Revenue Down as Multiple Sclerosis Sales Slide
Date:
Date:
Biogen swung to a loss as results were hurt by a double-digit decline in revenue from its core multiple sclerosis treatments.
Source link